ALPHA-1-ANTITRYPSIN DEFICIENCY IN CHILDREN
https://doi.org/10.21518/2079-701X-2017-9-166-170
Abstract
Hereditary deficiency of the alpha-1-antitrypsin occupies a leading position among the causes of chronic nonspecific lung diseases with emphysema formation. Deficiency of alpha-1-antitrypsin is a potentially fatal hereditary disease, under-diagnosed by physicians of various specialities. The authors familiarize pediatricians with this hereditary disease, difficulties of its diagnosis and treatment. There are presented own author`s data on the diagnosis and the experience of the enzyme replacement therapy of alpha-1-antitrypsin deficiency with the drug INN «Alpha-1 antitrypsin human» (Respikam).
About the Authors
S. I. MELNIK
North-Western State Medical University named after I.I. Mechnikov, Ministry of Public Health of the Russian Federation Health of Russia, Children’s Municipal Hospital №19 named after С.A. Rauhfus
Russian Federation
Russian Federation
M. V. PINEVSKAYA
North-Western State Medical University named after I.I. Mechnikov, Ministry of Public Health of the Russian Federation Health of Russia, Children’s Municipal Hospital №19 named after С.A. Rauhfus
Russian Federation
Russian Federation
E. A. ORLOVA
North-Western State Medical University named after I.I. Mechnikov, Ministry of Public Health of the Russian Federation Health of Russia, Children’s Municipal Hospital №19 named after С.A. Rauhfus
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
S. V. STAREVSKAYA
North-Western State Medical University named after I.I. Mechnikov, Ministry of Public Health of the Russian Federation Health of Russia, Children’s Municipal Hospital №19 named after С.A. Rauhfus
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
I. Y. MELNIKOVA
North-Western State Medical University named after I.I. Mechnikov, Ministry of Public Health of the Russian Federation Health of Russia
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
V. I. LARIONOVA
North-Western State Medical University named after I.I. Mechnikov, Ministry of Public Health of the Russian Federation Health of Russia
Russian Federation
MD
Russian Federation
MD
References
1. Vidal R et al. Diagnostico y tratamiento del deficit de alfa-1antitripsina Guidelines for the Diagnosis and Management of Alpha-1 Antitrypsin Deficiency. Arch. Bronconeumol., 2006 Dec, 42(12): 645-659.
2. α1-Antitrypsin deficiency: memorandum from a WHO meeting. WHO Bulletin OMS, 1997, 75(5): 397-415.
3. Katz RM, Lieberman J, Siegel SC. Alphalantitrypsin levels and prevalence of Pi variant phenotypes in asthmatic children. J Allergy Clin Immunol, 1976 Jan, 57(1): 41-5.
4. Crowther DC, Belorgey D, Miranda E, Kinghorn KJ, Sharp LK, Lomas DA. Practical genetics: alpha-1antitrypsin deficiency and the serpinopathies. Eur J Hum Genet, 2004 Mar, 12(3): 167-72.
5. Averyanov AV, Polivanova AE. Defitsit α1-antitripsina i khronicheskaia obstruktivnaia bolezn’ legkikh [Α1-antitrypsin deficiency and chronic obstructive pulmonary disease]. Pul’monologiia, 2007, 3: 103-9.
6. Hubbard RC, Crystal RG. Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route. Lung, 1990, 168(Suppl): 565-78.
7. Snyder MR, Katzmann JA, Butz ML et al. Diagnosis of α1antitrypsin deficiency: an algorithm of quantitation, geno typing, and phenotyping. Clin. Chem., 2006, 12: 2236-2242.
8. Churg A, Wang X, Wang RD, Meixner SC, Pryzdial EL, Wright JL. α1-Antitrypsin suppresses TNF-α and MMP-12 production by cigarette smoke-stimulated macrophages. Am J Respir Cell Mol Biol, 2007 Aug, 37(2): 144-51.
9. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factoralpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med, 1996 Feb, 153(2): 530-4.
10. Mueller R, Chanez P, Campbell AM, Bousquet J, Heusser C, Bullock GR. Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med, 1996 Feb, 90(2): 79-85.
11. Schwartz RH, Van Ess JD, Johnstone DE, Dreyfuss EM, Abrishami MA, Chai H. Alpha-1 antitrypsin in childhood asthma. J Allergy Clin Immunol, 1977 Jan, 59(1): 31-4.
12. Janciauskiene S, Larsson S, Larsson P, Virtala R, Jansson L, Stevens T. Inhibition of lipopolysaccharidemediated human monocyte activation, in vitro, by alpha1-antitrypsin.
13. Biochem Biophys Res Commun, 2004 Aug, 321(3): 592-600.
14. Crowther DC et al. Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies. Eur. J. Hum. Genet., 2004 Mar, 12(3): 167-172.
15. Castaldi PJ et al. Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency. Am. J. Epidemiol., 2009 Oct, 170(8): 1005-1013.
16. Davis ID et al. The pathologic spectrum of the nephropathy associated with α1-antitrypsin deficiency. Hum. Pathol., 1992 Jan, 23(1): 57-62.
17. Churg A et al. α1-Antitrypsin suppresses TNF-α and MMP-12 production by cigarette smokestimulated macrophages. Am. J. Respir. Cell Mol. Biol., 2007 Aug, 37(2): 144-151.
18. American Thoracic Society. European Respiratory Society Statement, American Journal of Respiratory and Critical Care Medicine. Am. J. Respir. Crit. Care Med., 2000, 168(7): 818-900.
19. Elzouki AN et al.Strong link between the alpha1-antitrypsin PiZ allele and Wegener’s granulomatosis. J. Intern. Med., 1994 Now, 236(5): 543-548.
20. Tanash HA, Nilsson PM, Nilsson JA et al. Survival in severe alpha-1-antitrypsin defi ciency (PiZZ). Respir. Res., 2010, 11: 44. PMID: 20420704.
21. Bornhorst J, Calderon F, Procter M et al. Genotypes and serum concentrations of human alpha 1 antitrypsin «P» protein variants in a clinical population. J. Clin. Pathol., 2007, 60: 1124-1128.
22. Standards for the Diagnosis and Management of Indi viduals with Alpha 1 Antitrypsin Deficiency. Am. J. Respirator. Crit. Care Med, 2003, 168: 818-900.
23. Frederick K. Askari Molecular mechanism of hepatocellu lar injury in alpha1 antitrypsin deficiency. Hepatology, 2005, 21(Iss. 6): 1745-1747.
24. Strange C, Dickson R, Carter C et al. Genetic testing for alpha 1antitrypsin deficiency. Genet. Med., 2004, 6: 204-210.
25. Keatings VM et al. Differences in interleukin-8 and tumor necrosis factoralpha in induced sputum from patients with chronic obs tructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med., 1996 Feb, 153(2): 530-534.
26. Needham M, Stockley RA. α1-аntitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax, 2004 May, 59(5): 441-445.
27. Katz RM, Lieberman J, Siegel SC. Alphalantitrypsin levels and prevalence of Pi variant phenotypes in asthmatic children. J. Allergy Clin. Immunol., 1976, 57(1): 41-45.
28. Bomhorst JA et al. Genotypes and serum concentrations of human alpha-1antitrypsin «P» protein variants in a clinical population. J. Clin. Pathol., 2007 Oct, 60(10): 1124-1128.
29. Katz RM, Bruttmann G. Alpha-1 antitrypsin levels and prevalence Bruttmann, G. Reagin asthma and familial alpha-1antitrypsin deficiency. Nouv. Presse Med., 1974 Mar, 3(10): 589-591.
Review
For citations:
MELNIK SI, PINEVSKAYA MV, ORLOVA EA, STAREVSKAYA SV, MELNIKOVA IY, LARIONOVA VI. ALPHA-1-ANTITRYPSIN DEFICIENCY IN CHILDREN. Meditsinskiy sovet = Medical Council. 2017;(9):166-170. (In Russ.) https://doi.org/10.21518/2079-701X-2017-9-166-170
Views:
842
Email this article 